Natural Alternatives International Inc. (NAII) Financial Statements (2025 and earlier)

Company Profile

Business Address 1535 FARADAY AVENUE
CARLSBAD, CA 92008-7319
State of Incorp. DE
Fiscal Year End June 30
Industry (SIC) 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2024
Q2
9/30/2024
Q1
6/30/2024
Q4
3/31/2024
Q3
12/31/2023
Q2
9/30/2023
Q1
6/30/2023
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments10,15611,98112,40716,59516,749 
Cash and cash equivalent10,15611,98112,40716,59516,749 
Receivables17,62316,89112,88311,33810,089 
Inventory, net of allowances, customer advances and progress billings25,92724,24921,07119,59623,304 
Inventory25,92724,24921,07119,59623,304 
Derivative instruments and hedges, assets31492335414787 
Other undisclosed current assets8,7447,9977,6656,4506,825 
Total current assets:62,48161,61054,36154,39357,754 
Noncurrent Assets
Operating lease, right-of-use asset42,91943,53744,03244,99445,651 
Property, plant and equipment51,06052,21152,38453,20753,971 
Deferred income tax assets3,3343,170291321161 
Other noncurrent assets1,4761,8142,1432,8182,715 
Total noncurrent assets:98,789100,73298,850101,340102,498 
TOTAL ASSETS:161,270162,342153,211155,733160,252 
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities12,65415,5879,3959,50110,329 
Accounts payable9,94512,7406,9707,4947,614 
Accrued liabilities2,7092,8472,4252,0072,715 
Deferred revenue636302387695405 
Debt5,6983,696294292290 
Derivative instruments and hedges, liabilities5439134538720 
Other undisclosed current liabilities4,9023,7893,2262,8863,693 
Total current liabilities:24,43323,46513,64713,41215,437 
Noncurrent Liabilities
Long-term debt and lease obligation8,8588,9339,0079,0799,154 
Long-term debt, excluding current maturities8,8588,9339,0079,0799,154 
Liabilities, other than long-term debt47,79447,34946,45847,78746,846 
Accounts payable and accrued liabilities740740740740740 
Liability, pension and other postretirement and postemployment benefits144141295346328 
Operating lease, liability46,91046,46845,42346,70145,778 
Total noncurrent liabilities:56,65256,28255,46556,86656,000 
Total liabilities:81,08579,74769,11270,27871,437 
Equity
Equity, attributable to parent80,18582,59584,09985,45588,815 
Common stock9393939191 
Treasury stock, value(23,084)(23,076)(23,072)(22,855)(22,855) 
Additional paid in capital32,91032,63432,35632,04331,738 
Accumulated other comprehensive income (loss)(718)(22)(118)(242)353 
Retained earnings70,98472,96674,84076,41879,488 
Total equity:80,18582,59584,09985,45588,815 
TOTAL LIABILITIES AND EQUITY:161,270162,342153,211155,733160,252 

Income Statement (P&L) ($ in thousands)

12/31/2024
Q2
9/30/2024
Q1
6/30/2024
Q4
3/31/2024
Q3
12/31/2023
Q2
9/30/2023
Q1
6/30/2023
Q4
Revenues33,15029,48925,13625,20233,969 
Cost of revenue
(Cost of Product and Service Sold)
(30,891)(28,070)(23,214)(24,815)(30,832) 
Gross profit:2,2591,4191,9223873,137 
Operating expenses(4,095)(3,944)(3,874)(3,900)(3,681) 
Operating loss:(1,836)(2,525)(1,952)(3,513)(544) 
Nonoperating expense(577)(256)(16)(318)(340) 
Investment income, nonoperating337679139 
Gain (loss), foreign currency transaction, before tax(431)(112)(23)(240)(277) 
Other nonoperating income (expense)(1)(96)2(21)21 
Loss from continuing operations before income taxes:(2,413)(2,781)(1,968)(3,831)(884) 
Income tax benefit431907390761189 
Net loss available to common stockholders, diluted:(1,982)(1,874)(1,578)(3,070)(695) 

Comprehensive Income ($ in thousands)

12/31/2024
Q2
9/30/2024
Q1
6/30/2024
Q4
3/31/2024
Q3
12/31/2023
Q2
9/30/2023
Q1
6/30/2023
Q4
Net loss:(1,982)(1,874)(1,578)(3,070)(695) 
Other undisclosed comprehensive income  127    
Comprehensive loss:(1,982)(1,747)(1,578)(3,070)(695) 
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(682)(36)119(590)441 
Comprehensive loss, net of tax, attributable to parent:(2,664)(1,783)(1,459)(3,660)(254) 

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: